For citations:
Karateev D.E., Luchikhina E.L., Demidova N.V., Gridneva G.S., Lukina G.V., Kanonirova M.A., Muravyev Yu.V., Kasumova K.A., Aleksandrova E.N., Novikov A.A., Avdeeva A.S., Nasonov E.L. USE OF SUBCUTANEOUS METHOTREXATE FOR THE TREATMENT OF PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS: THE REMARCA TRIAL. Rheumatology Science and Practice. 2016;54(2):138-144. (In Russ.) https://doi.org/10.14412/1995-4484-2016-138-144
Email this article 